Vincent Libis

Vincent Libis is a Research Group Leader at INSERM, where they focus on discovering novel bioactive microbial metabolites for the development of antibiotics and other medicinal compounds. With a background that includes co-founding Abolis Biotechnologies SAS and Generare Bioscience, Vincent has extensive experience in synthetic biology and drug discovery. They completed a PhD in Synthetic Biology at Université Paris Cité, following a Doctor of Pharmacy degree from Université de Strasbourg. Previously, Vincent was a postdoctoral researcher at Rockefeller University and contributed to award-winning projects in synthetic biology, notably with the iGEM Paris Bettencourt team.